GRAIL, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
GRAIL, Inc. (GRAL) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$540.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- GRAIL, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$540.19M.
- GRAIL, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$2.17B.
- GRAIL, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$1.51B.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$540.19M 10-K · filed 2026-03-12 |
| 2024-12-31 | -$2.17B 10-K · filed 2026-03-12 |
| 2023-12-31 | -$1.51B 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |